According to the characteristics of drugs and development plans, we match more suitable leading PIs, leading sites, investigators, and sub-centers by taking into account the academic influence, project competitiveness, and experience in large-scale clinical trials. We explore and expand patient recruitment sources through multiple channels, comprehensively control project quality management and risks, and assist the quick application to authorities for the products.